Weight‐loss drugs improve outcomes in patients with alcohol use disorder

Use of the glucagon‐like peptide‐1 (GLP‐1) receptor agonist semaglutide was associated with reduced risk of alcohol‐related hospitalization in patients with alcohol use disorder (AUD), a cohort study has found. Both semaglutide and the GLP‐1 receptor agonist liraglutide were associated with lower risk of hospitalization than use of medication treatments for AUD. Study results were published online Nov. 13, 2024, in JAMA Psychiatry .

Publication Details

Journal
The Brown University Psychopharmacology Update
Published
2025-01-29
DOI
https://doi.org/10.1002/pu.31274
Primary Topic
Diet and metabolism studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Weight‐loss drugs improve outcomes in patients with alcohol use disorder

The Brown University Psychopharmacology Update
Diet and metabolism studies
article

Weight‐loss drugs improve outcomes in patients with alcohol use disorder

article en

Abstract

Use of the glucagon‐like peptide‐1 (GLP‐1) receptor agonist semaglutide was associated with reduced risk of alcohol‐related hospitalization in patients with alcohol use disorder (AUD), a cohort study has found. Both semaglutide and the GLP‐1 receptor agonist liraglutide were associated with lower risk of hospitalization than use of medication treatments for AUD. Study results were published online Nov. 13, 2024, in JAMA Psychiatry .

The Brown University Psychopharmacology UpdateVol. 36(3)
Openalex Percentile: Top 98%
Diet and metabolism studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Weight‐loss drugs improve outcomes in patients with alcohol use disorder · The Brown University Psychopharmacology Update (2025) | TGRS Research Map | TGRS